Major publications in the critical care pharmacotherapy literature: 2019 Article

Full Text via DOI: 10.1016/j.jcrc.2020.12.018 Web of Science: 000631886200030

Cited authors

  • Condeni MS, Basting AT, Costello PG, DePriest A, Eriksson EA, Evans H, Hertel K, Holder AL, Kester AN, Kowalski KR, Bell CM, McLean B, Reichert M, Santibanez M, Wieruszewski PM, Newsome AS

Abstract

  • Purpose: To summarize selected meta-analyses and trials related to critical care pharmacotherapy published in 2019.Materials and methods: The Critical Care Pharmacotherapy Literature Update (CCPLU) Group screened 36 journals monthly for impactful articles and reviewed 113 articles during 2019 according to Grading of Recommendations, Assessment, Development, and Evaluations (GRADE) criteria.Results: Articles with a 1A grade, including three clinical practice guidelines, six meta-analyses, and five original research trials are reviewed here from those included in the monthly CCPLU. Clinical practice guidelines on the use of polymyxins and antiarrhythmic drugs in cardiac arrest as well as meta-analyses on antipsychotic use in delirium, stress ulcer prophylaxis (SUP), and vasoactive medications in septic shock and cardiac arrest were summarized. Original research trials evaluated delirium, sedation, neuromuscular blockade, SUP, anticoagulation reversal, and hemostasis.Conclusion: This clinical review and expert opinion provides summary and perspectives of clinical practice impact on influential critical care pharmacotherapy publications in 2019.(c) 2020 Elsevier Inc. All rights reserved.

Publication date

  • 2021

Published in

Category

International Standard Serial Number (ISSN)

  • 0883-9441

Number of pages

  • 9

Start page

  • 197

End page

  • 205

Volume

  • 62